Average Insider

Where insiders trade, we follow

$FTRE
Fortrea Holdings Inc., a contract research organization, primarily engages in the provision of biopharmaceutical product and medical device development services worldwide. It operates through two segments: Clinical Services and Enabling Services. The Clinical Services segment provides across the clinical pharmacology and clinical development spectrum. The Enabling Services segment provides patient access and clinical trial technology solutions to customers that streamline complex randomization and optimize the trial drug supply process. The company offers delivery models that include full service, functional service provider, and hybrid service structures. It also offers phase I-IV clinical trial management, differentiated technology enabled trial solutions, and post approval services. The company serves pharmaceutical, biotechnology, and medical device organizations. Fortrea Holdings Inc. was incorporated in 2023 and is based in Durham, North Carolina.
Healthcare
Sector
Biotechnology
Industry
Anshul Thakral
CEO
15000
Employees
$20.50
Current Price
$1.07B
Market Cap
52W Low$8.55
Current$20.5067.9% above low, 32.1% below high
52W High$26.16

Insider Activity Statistics

Aggregated buying and selling activity by time period
PeriodTypeInsidersTransactionsValueSharesBuy/Sell Ratio
1 weekBuys00---
Sells00--
2 weeksBuys00---
Sells00--
1 monthBuys00---
Sells00--
2 monthsBuys00---
Sells00--
3 monthsBuys00--All Sells
Sells22$57,205.753,395
See activity going back 12 months โ€” create a free account

Insider Transactions

Recent purchases and sales by company insiders
DateInsiderTypeSharesPriceValueActions
Sep 9, 2026
Russell Carrie Elizabeth
Interim CAO
Sale246$16.85$4,145.10View Details
Sep 9, 2026
Morais Mark A.
Chief Operating Officer
Sale3,149$16.85$53,060.65View Details
22 more transactions available โ€” create a free account to see 12 months of history

Upcoming Earnings

Scheduled earnings reports
No upcoming earnings scheduled

Past Earnings

Historical earnings results
Oct 29, 2026
EPS
Estimated$0.22
ActualN/A
Revenue
Estimated$671.57M
ActualN/A
1 more earnings records available โ€” create a free account to see 12 months of history
Version: v26.11.1